NRx Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Prepaid Expenses and Other Current Assets

9 Months Ended

Sep. 30, 2022

5. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following at the dates indicated (in thousands):


	September 30, 2022		December 31, 2021
	(Unaudited)
Prepaid expenses and other current assets:
Prepaid insurance	$	4,853	$	3,224
Other prepaid expenses		555		345
Receivable due from manufacturer		547		—
Prepaid clinical development expenses		316		512
Prepaid legal expenses		281		—
Prepaid manufacturing expenses		—		1,028
Total prepaid expenses and other current assets	$	6,552	$	5,109